BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23441184)

  • 1. Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.
    Lund H; Krakauer M; Skimminge A; Sellebjerg F; Garde E; Siebner HR; Paulson OB; Hesse D; Hanson LG
    PLoS One; 2013; 8(2):e56375. PubMed ID: 23441184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of subtle blood brain barrier disruption in a placebo-controlled trial of natalizumab in relapsing remitting multiple sclerosis.
    Soon D; Altmann DR; Fernando KT; Giovannoni G; Barkhof F; Polman CH; O'Connor P; Gray B; Panzara M; Miller DH
    J Neurol; 2007 Mar; 254(3):306-14. PubMed ID: 17277910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.
    Choi S; Spini M; Hua J; Harrison DM
    PLoS One; 2021; 16(4):e0249973. PubMed ID: 33901207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter.
    Law M; Saindane AM; Ge Y; Babb JS; Johnson G; Mannon LJ; Herbert J; Grossman RI
    Radiology; 2004 Jun; 231(3):645-52. PubMed ID: 15163806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal blood-brain barrier water exchange in chronic multiple sclerosis lesions: A preliminary study.
    Wengler K; Ha J; Syritsyna O; Bangiyev L; Coyle PK; Duong TQ; Schweitzer ME; He X
    Magn Reson Imaging; 2020 Jul; 70():126-133. PubMed ID: 32353529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between lesion and normal appearing brain tissue abnormalities in early relapsing remitting multiple sclerosis.
    Griffin CM; Chard DT; Parker GJ; Barker GJ; Thompson AJ; Miller DH
    J Neurol; 2002 Feb; 249(2):193-9. PubMed ID: 11985386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative study of water diffusion in multiple sclerosis lesions and normal-appearing white matter using echo-planar imaging.
    Filippi M; Iannucci G; Cercignani M; Assunta Rocca M; Pratesi A; Comi G
    Arch Neurol; 2000 Jul; 57(7):1017-21. PubMed ID: 10891984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal appearing white matter permeability: a marker of inflammation and information processing speed deficit among relapsing remitting multiple sclerosis patients.
    Eftekhari E; Hojjat SP; Vitorino R; Carroll TJ; Cantrell CG; Lee L; Taylor MW; Morrow SA; Benhabib H; Aviv RI; Kassner A
    Neuroradiology; 2017 Aug; 59(8):771-780. PubMed ID: 28623483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative T1 mapping detects blood-brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions.
    Donatelli G; Cecchi P; Migaleddu G; Cencini M; Frumento P; D'Amelio C; Peretti L; Buonincontri G; Pasquali L; Tosetti M; Cosottini M; Costagli M
    Neuroimage Clin; 2023; 40():103509. PubMed ID: 37717382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis.
    Vrenken H; Geurts JJ; Knol DL; Polman CH; Castelijns JA; Pouwels PJ; Barkhof F
    AJNR Am J Neuroradiol; 2006 Oct; 27(9):2005-11. PubMed ID: 17032884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Contrast-Enhanced Magnetic Resonance Imaging Suggests Normal Perfusion in Normal-Appearing White Matter in Multiple Sclerosis.
    Ingrisch M; Sourbron S; Herberich S; Schneider MJ; Kümpfel T; Hohlfeld R; Reiser MF; Ertl-Wagner B
    Invest Radiol; 2017 Mar; 52(3):135-141. PubMed ID: 27548346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter.
    Vrenken H; Rombouts SA; Pouwels PJ; Barkhof F
    AJNR Am J Neuroradiol; 2006 Apr; 27(4):868-74. PubMed ID: 16611780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
    Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
    Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.
    Varga AW; Johnson G; Babb JS; Herbert J; Grossman RI; Inglese M
    J Neurol Sci; 2009 Jul; 282(1-2):28-33. PubMed ID: 19181347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment.
    Panou Τ; Kavroulakis E; Mastorodemos V; Pouli S; Kalaitzakis G; Spyridaki E; Maris TG; Simos P; Papadaki E
    Mult Scler Relat Disord; 2021 Sep; 54():103108. PubMed ID: 34198031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal blood-brain barrier permeability in normal appearing white matter in multiple sclerosis investigated by MRI.
    Cramer SP; Simonsen H; Frederiksen JL; Rostrup E; Larsson HB
    Neuroimage Clin; 2014; 4():182-9. PubMed ID: 24371801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative T
    Harper JG; York EN; Meijboom R; Kampaite A; Thrippleton MJ; Kearns PKA; Valdés Hernández MDC; Chandran S; Waldman AD;
    Eur Radiol; 2024 Jun; 34(6):3826-3839. PubMed ID: 37943312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of subtle blood-brain barrier disruption in non-enhancing lesions in multiple sclerosis: a study of disease and lesion subtypes.
    Soon D; Tozer D; Altmann D; Tofts P; Miller D
    Mult Scler; 2007 Aug; 13(7):884-94. PubMed ID: 17468443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-brain barrier permeability measured using dynamic contrast-enhanced magnetic resonance imaging: a validation study.
    Varatharaj A; Liljeroth M; Darekar A; Larsson HBW; Galea I; Cramer SP
    J Physiol; 2019 Feb; 597(3):699-709. PubMed ID: 30417928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal-appearing grey and white matter T1 abnormality in early relapsing-remitting multiple sclerosis: a longitudinal study.
    Davies GR; Hadjiprocopis A; Altmann DR; Chard DT; Griffin CM; Rashid W; Parker GJ; Tofts PS; Kapoor R; Thompson AJ; Miller DH
    Mult Scler; 2007 Mar; 13(2):169-77. PubMed ID: 17439881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.